Lecia V Sequist Selected Research

Lecia V Sequist Research Topics

Disease

96	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 08/2005
90	Neoplasms (Cancer) 04/2024 - 07/2006
62	Lung Neoplasms (Lung Cancer) 11/2023 - 07/2006
21	Disease Progression 01/2023 - 08/2009
14	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2007
13	Adenocarcinoma of Lung 06/2023 - 07/2007
10	Circulating Neoplastic Cells 03/2024 - 07/2008
6	Adenocarcinoma 01/2019 - 07/2007
6	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 03/2010
5	Fatigue 06/2023 - 09/2013
5	Dyspnea (Shortness of Breath) 06/2023 - 09/2013
4	Diarrhea 06/2023 - 06/2010
4	Cough 06/2023 - 09/2013
4	Exanthema (Rash) 06/2023 - 09/2013
4	Pain (Aches) 06/2023 - 09/2013
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 10/2010
4	Melanoma (Melanoma, Malignant) 01/2018 - 07/2012
4	Brain Neoplasms (Brain Tumor) 01/2018 - 11/2014
3	Acne Vulgaris 06/2023 - 09/2013
3	Stomatitis 06/2023 - 09/2013
3	Nausea 06/2023 - 09/2013
3	Central Nervous System Diseases (CNS Diseases) 06/2022 - 01/2018
3	Pneumonia (Pneumonitis) 01/2021 - 05/2008
3	Epilepsy (Aura) 01/2019 - 04/2017
2	Lymphoma (Lymphomas) 04/2024 - 05/2012
2	Carcinoma (Carcinomatosis) 04/2024 - 12/2012
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 02/2015
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2016
2	Neutropenia 11/2016 - 02/2015
1	Neuroendocrine Carcinoma 04/2024
1	Edema (Dropsy) 08/2023
1	Genomic Instability 08/2023
1	COVID-19 01/2021
1	medullary Thyroid cancer 01/2020

Drug/Important Bio-Agent (IBA)

74	ErbB Receptors (EGF Receptor)IBA 01/2023 - 08/2005
49	Tyrosine Kinase InhibitorsIBA 05/2024 - 01/2007
22	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019 - 07/2006
15	RNA (Ribonucleic Acid)IBA 03/2024 - 03/2010
14	osimertinibIBA 04/2024 - 04/2016
14	AfatinibIBA 06/2023 - 05/2012
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2007
11	Gefitinib (Iressa)FDA Link 01/2019 - 07/2006
10	Phosphotransferases (Kinase)IBA 01/2022 - 08/2005
9	CrizotinibIBA 08/2023 - 06/2010
9	Pemetrexed (MTA)FDA Link 06/2023 - 10/2008
9	PlatinumIBA 01/2022 - 02/2010
8	Cisplatin (Platino)FDA LinkGeneric 06/2023 - 11/2008
8	Anaplastic Lymphoma KinaseIBA 01/2020 - 06/2010
7	Proteins (Proteins, Gene)FDA Link 03/2024 - 06/2007
7	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 05/2008
7	rociletinibIBA 11/2018 - 01/2015
5	Immune Checkpoint InhibitorsIBA 01/2021 - 06/2015
4	Circulating Tumor DNAIBA 01/2020 - 03/2016
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018 - 07/2012
4	ARQ 197IBA 01/2018 - 08/2011
3	alectinibIBA 08/2023 - 10/2016
3	lorlatinibIBA 10/2022 - 01/2021
3	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2008
3	nazartinibIBA 01/2022 - 01/2018
3	Docetaxel (Taxotere)FDA Link 01/2019 - 01/2015
3	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2019 - 12/2012
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 03/2013
3	pembrolizumabIBA 01/2019 - 11/2016
3	Androgen Receptors (Androgen Receptor)IBA 11/2017 - 11/2012
3	Carboplatin (JM8)FDA LinkGeneric 11/2016 - 11/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2010 - 07/2006
2	capmatinibIBA 08/2023 - 01/2021
2	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2023 - 01/2020
2	cabozantinibIBA 01/2022 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2017
2	olaparibIBA 10/2019 - 10/2013
2	Messenger RNA (mRNA)IBA 01/2019 - 12/2018
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 12/2018 - 01/2018
2	NivolumabIBA 10/2018 - 06/2015
2	Complement System Proteins (Complement)IBA 12/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 11/2017 - 01/2017
2	EpitopesIBA 10/2017 - 04/2013
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017 - 12/2014
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2015 - 10/2012
2	AndrogensIBA 09/2015 - 11/2012
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2013 - 11/2010
1	GuanineIBA 09/2023
1	Poly GIBA 09/2023
1	CarcinogensIBA 09/2023
1	Cytidine DeaminaseIBA 08/2023
1	B7-H1 AntigenIBA 09/2022
1	entrectinibIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	SolventsIBA 01/2020

Therapy/Procedure

75	Therapeutics 04/2024 - 07/2006
29	Drug Therapy (Chemotherapy) 06/2023 - 02/2007
9	Radiotherapy 01/2022 - 02/2015
4	Drug Tapering 11/2023 - 06/2010
3	Immunotherapy 01/2022 - 01/2015
3	Aftercare (After-Treatment) 01/2018 - 06/2007
3	Castration 01/2018 - 11/2012
3	Lab-On-A-Chip Devices 11/2014 - 07/2008
1	Chemoradiotherapy 05/2024
1	Surgical Instruments (Clip) 01/2020